PT2432766E - Composto anti-canceroso e composição farmacêutica que o contém - Google Patents

Composto anti-canceroso e composição farmacêutica que o contém

Info

Publication number: PT2432766E
Authority: PT; Portugal
Prior art keywords: compound; same; pharmaceutical composition; composition containing; anticancer compound
Prior art date: 2009-05-18

Application number

PT107287682T

Other languages

English (en)

Inventor

Jean-Christophe Carry

Michel Cheve

Francois Clerc

Cecile Combeau

Sylvie Gontier

Alain Krick

Sylvette Lachaud

Laurent Schio

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-18

Filing date

2010-05-17

Publication date

2013-10-23

2010-05-17 Application filed by Sanofi Sa filed Critical Sanofi Sa

2013-10-23 Publication of PT2432766E publication Critical patent/PT2432766E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PT107287682T 2009-05-18 2010-05-17 Composto anti-canceroso e composição farmacêutica que o contém PT2432766E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0902392A FR2945535B1 (fr)	2009-05-18	2009-05-18	Compose anticancereux et composition pharmaceutique le contenant

Publications (1)

Publication Number	Publication Date
PT2432766E true PT2432766E (pt)	2013-10-23

Family

ID=40973187

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT107287682T PT2432766E (pt)	2009-05-18	2010-05-17	Composto anti-canceroso e composição farmacêutica que o contém

Country Status (35)

Country	Link
US (2)	US9073917B2 (pt)
EP (1)	EP2432766B1 (pt)
JP (1)	JP5656981B2 (pt)
KR (1)	KR20120032483A (pt)
CN (1)	CN102459193B (pt)
AR (1)	AR076686A1 (pt)
AU (1)	AU2010251013B2 (pt)
BR (1)	BRPI1012201A2 (pt)
CA (1)	CA2762233C (pt)
CL (1)	CL2011002930A1 (pt)
CO (1)	CO6400138A2 (pt)
CY (1)	CY1114850T1 (pt)
DK (1)	DK2432766T3 (pt)
EA (1)	EA021084B1 (pt)
ES (1)	ES2430989T3 (pt)
FR (1)	FR2945535B1 (pt)
HK (1)	HK1167388A1 (pt)
HR (1)	HRP20130959T1 (pt)
IL (1)	IL216361A0 (pt)
JO (1)	JO2852B1 (pt)
MA (1)	MA33356B1 (pt)
ME (1)	ME01542B (pt)
MX (1)	MX2011012356A (pt)
MY (1)	MY152995A (pt)
NZ (1)	NZ596464A (pt)
PL (1)	PL2432766T3 (pt)
PT (1)	PT2432766E (pt)
RS (1)	RS53002B (pt)
SG (1)	SG176169A1 (pt)
SI (1)	SI2432766T1 (pt)
SM (1)	SMT201400005B (pt)
TW (1)	TWI441822B (pt)
UY (1)	UY32644A (pt)
WO (1)	WO2010133794A1 (pt)
ZA (1)	ZA201108447B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2945535B1 (fr)	2009-05-18	2011-06-10	Sanofi Aventis	Compose anticancereux et composition pharmaceutique le contenant
FR2967413A1 (fr) *	2010-11-17	2012-05-18	Sanofi Aventis	Compose 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)-phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate d'ethyle, sel, forme cristalline, co-cristal, formulation, procedes de preparation, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteur des kinases aurora.
LT2909204T (lt)	2012-10-12	2019-05-10	The Broad Institute, Inc.	Gsk3 inhibitoriai ir jų panaudojimo būdai
EA031262B1 (ru)	2014-07-01	2018-12-28	Такеда Фармасьютикал Компани Лимитед	Гетероциклические соединения и их применение в качестве ингибиторов орфанного рецептора гамма-t, родственного рецепторам ретиноидов (ror)
EP3606528B1 (en)	2017-04-05	2023-10-18	The Broad Institute, Inc.	Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2391291A1 (en)	1999-11-19	2001-05-25	Abbott Laboratories	Tricyclic dihydropyrimidine potassium channel openers
CN1630656A (zh)	2001-02-02	2005-06-22	三菱制药株式会社	二氢吡唑并吡啶化合物及其制药用途
US7037902B2 (en)	2002-07-03	2006-05-02	Receptron, Inc.	Affinity small molecules for the EPO receptor
WO2005016245A2 (en)	2003-06-13	2005-02-24	Zentaris Gmbh	Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
RS51351B (en) *	2005-07-20	2011-02-28	Aventis Pharma S.A.	1,4-DIHYDROPYRIDINE-CONDENSED HTEROCYCLES, PROCEDURES FOR THEIR PRODUCTION, USE AND THE COMPOSITIONS CONTAINING THEM
FR2945535B1 (fr)	2009-05-18	2011-06-10	Sanofi Aventis	Compose anticancereux et composition pharmaceutique le contenant

2009
- 2009-05-18 FR FR0902392A patent/FR2945535B1/fr not_active Expired - Fee Related
2010
- 2010-05-16 JO JO2010163A patent/JO2852B1/en active
- 2010-05-17 CA CA2762233A patent/CA2762233C/fr not_active Expired - Fee Related
- 2010-05-17 MA MA34441A patent/MA33356B1/fr unknown
- 2010-05-17 MX MX2011012356A patent/MX2011012356A/es active IP Right Grant
- 2010-05-17 MY MYPI2011005531 patent/MY152995A/en unknown
- 2010-05-17 CN CN201080032327.7A patent/CN102459193B/zh not_active Expired - Fee Related
- 2010-05-17 ES ES10728768T patent/ES2430989T3/es active Active
- 2010-05-17 PL PL10728768T patent/PL2432766T3/pl unknown
- 2010-05-17 DK DK10728768.2T patent/DK2432766T3/da active
- 2010-05-17 NZ NZ596464A patent/NZ596464A/en not_active IP Right Cessation
- 2010-05-17 AU AU2010251013A patent/AU2010251013B2/en not_active Ceased
- 2010-05-17 TW TW099115713A patent/TWI441822B/zh not_active IP Right Cessation
- 2010-05-17 BR BRPI1012201A patent/BRPI1012201A2/pt not_active IP Right Cessation
- 2010-05-17 ME MEP-2013-121A patent/ME01542B/me unknown
- 2010-05-17 KR KR1020117030136A patent/KR20120032483A/ko active Search and Examination
- 2010-05-17 RS RS20130444A patent/RS53002B/en unknown
- 2010-05-17 PT PT107287682T patent/PT2432766E/pt unknown
- 2010-05-17 EP EP10728768.2A patent/EP2432766B1/fr active Active
- 2010-05-17 JP JP2012511323A patent/JP5656981B2/ja not_active Expired - Fee Related
- 2010-05-17 WO PCT/FR2010/050948 patent/WO2010133794A1/fr active Application Filing
- 2010-05-17 EA EA201171429A patent/EA021084B1/ru not_active IP Right Cessation
- 2010-05-17 AR ARP100101705A patent/AR076686A1/es unknown
- 2010-05-17 SG SG2011085529A patent/SG176169A1/en unknown
- 2010-05-17 SI SI201030384T patent/SI2432766T1/sl unknown
- 2010-05-17 US US13/320,965 patent/US9073917B2/en not_active Expired - Fee Related
- 2010-05-18 UY UY0001032644A patent/UY32644A/es not_active Application Discontinuation
2011
- 2011-11-14 IL IL216361A patent/IL216361A0/en unknown
- 2011-11-17 ZA ZA2011/08447A patent/ZA201108447B/en unknown
- 2011-11-18 CO CO11157425A patent/CO6400138A2/es active IP Right Grant
- 2011-11-18 CL CL2011002930A patent/CL2011002930A1/es unknown
2012
- 2012-08-15 HK HK12108002.5A patent/HK1167388A1/xx not_active IP Right Cessation
2013
- 2013-10-09 HR HRP20130959AT patent/HRP20130959T1/hr unknown
- 2013-10-17 CY CY20131100920T patent/CY1114850T1/el unknown
2014
- 2014-01-16 SM SM201400005T patent/SMT201400005B/xx unknown
2015
- 2015-06-02 US US14/728,846 patent/US9221817B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL216361A0 (en)	2012-01-31
EA021084B1 (ru)	2015-04-30
FR2945535A1 (fr)	2010-11-19
CY1114850T1 (el)	2016-12-14
US20120220621A1 (en)	2012-08-30
US9073917B2 (en)	2015-07-07
CA2762233A1 (fr)	2010-11-25
DK2432766T3 (da)	2013-10-28
TWI441822B (zh)	2014-06-21
KR20120032483A (ko)	2012-04-05
EP2432766B1 (fr)	2013-07-17
JP5656981B2 (ja)	2015-01-21
CN102459193A (zh)	2012-05-16
CO6400138A2 (es)	2012-03-15
AU2010251013B2 (en)	2015-08-20
HRP20130959T1 (hr)	2013-11-22
MA33356B1 (fr)	2012-06-01
ES2430989T3 (es)	2013-11-22
HK1167388A1 (en)	2012-11-30
CA2762233C (fr)	2017-11-28
MY152995A (en)	2014-12-31
MX2011012356A (es)	2011-12-14
RS53002B (en)	2014-04-30
SMT201400005B (it)	2014-03-07
BRPI1012201A2 (pt)	2016-04-05
AR076686A1 (es)	2011-06-29
SI2432766T1 (sl)	2013-11-29
CL2011002930A1 (es)	2012-06-29
PL2432766T3 (pl)	2013-12-31
ME01542B (me)	2014-04-20
EP2432766A1 (fr)	2012-03-28
NZ596464A (en)	2014-01-31
UY32644A (es)	2010-12-31
US20150266877A1 (en)	2015-09-24
US9221817B2 (en)	2015-12-29
ZA201108447B (en)	2013-01-30
AU2010251013A1 (en)	2011-12-08
JO2852B1 (en)	2015-03-15
CN102459193B (zh)	2014-08-27
TW201100418A (en)	2011-01-01
FR2945535B1 (fr)	2011-06-10
JP2012527436A (ja)	2012-11-08
WO2010133794A1 (fr)	2010-11-25
EA201171429A1 (ru)	2012-05-30
SG176169A1 (en)	2011-12-29

Publication	Publication Date	Title
UA94052C2 (uk)	2011-04-11	Похідні піридазину
SG148178A1 (en)	2008-12-31	Indozolone derivatives as 11b-hsd1 inhibitors
DE602006021539D1 (en)	2011-06-09	Morpholine als 5ht2c-agonisten
TW200608972A (en)	2006-03-16	Aryl-pyridine derivatives
MX2011012627A (es)	2011-12-14	Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
GB0114286D0 (en)	2001-08-01	Nucleoside Derivatives
MX2010006799A (es)	2010-10-05	Benzofuropirimidinonas como inhibidores de la proteina cinasa.
GEP20125459B (en)	2012-03-26	Compounds for inhibiting mitotic progression
EA018193B3 (ru)	2014-07-30	Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
MX2010005824A (es)	2010-06-11	Derivados de aminotiazol.
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IN2012DN03337A (pt)	2015-10-23
WO2008143240A1 (ja)	2008-11-27	特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
TW200740764A (en)	2007-11-01	Pyrazolone derivatives
MX2008016426A (es)	2009-01-19	Derivados de alquilpiridazina como inhibidores de 11 beta hidroxiesteroide deshidrogenasa tipo 1(11b-hsd 1).
HK1167388A1 (en)	2012-11-30	Anticancer compound and pharmaceutical composition containing the same
MY143568A (en)	2011-05-31	11b-hsd1 inhibitors for the treatment of diabetes
MX2009003169A (es)	2009-04-03	Derivados de sulfonamida.
MX2012007225A (es)	2012-07-30	Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
MY139522A (en)	2009-10-30	New alkyl-pyridines as 11-beta inhibitors for diabetes
TW200630364A (en)	2006-09-01	2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX2009004295A (es)	2009-05-05	Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
IL191670A0 (en)	2008-12-29	Compounds for the inhibition of apoptosis
TW200738703A (en)	2007-10-16	2-Carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TH135249A (th)	2014-07-21	สารประกอบตัวยับยั้งออโรราต้านมะเร็งและองค์ประกอบทางเภสัชกรรมที่มีสารดังกล่าว, กระบวนการและอินเทอร์มิเดียทสำหรับการเตรียมสารเหล่านั้น